West Pharmaceutical Services Total Current Assets 2010-2024 | WST

West Pharmaceutical Services total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • West Pharmaceutical Services total current assets for the quarter ending June 30, 2024 were $1.483B, a 20.87% decline year-over-year.
  • West Pharmaceutical Services total current assets for 2023 were $1.936B, a 0.88% increase from 2022.
  • West Pharmaceutical Services total current assets for 2022 were $1.92B, a 10.19% increase from 2021.
  • West Pharmaceutical Services total current assets for 2021 were $1.742B, a 26.81% increase from 2020.
West Pharmaceutical Services Annual Total Current Assets
(Millions of US $)
2023 $1,936
2022 $1,920
2021 $1,742
2020 $1,374
2019 $1,059
2018 $894
2017 $744
2016 $642
2015 $674
2014 $659
2013 $651
2012 $557
2011 $472
2010 $437
2009 $397
West Pharmaceutical Services Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $1,483
2024-03-31 $1,693
2023-12-31 $1,936
2023-09-30 $1,972
2023-06-30 $1,874
2023-03-31 $1,937
2022-12-31 $1,920
2022-09-30 $1,734
2022-06-30 $1,771
2022-03-31 $1,691
2021-12-31 $1,742
2021-09-30 $1,598
2021-06-30 $1,477
2021-03-31 $1,327
2020-12-31 $1,374
2020-09-30 $1,238
2020-06-30 $1,111
2020-03-31 $978
2019-12-31 $1,059
2019-09-30 $1,004
2019-06-30 $944
2019-03-31 $868
2018-12-31 $894
2018-09-30 $850
2018-06-30 $767
2018-03-31 $744
2017-12-31 $744
2017-09-30 $777
2017-06-30 $718
2017-03-31 $653
2016-12-31 $642
2016-09-30 $658
2016-06-30 $659
2016-03-31 $631
2015-12-31 $674
2015-09-30 $681
2015-06-30 $680
2015-03-31 $625
2014-12-31 $659
2014-09-30 $680
2014-06-30 $685
2014-03-31 $687
2013-12-31 $651
2013-09-30 $644
2013-06-30 $613
2013-03-31 $590
2012-12-31 $557
2012-09-30 $557
2012-06-30 $517
2012-03-31 $503
2011-12-31 $472
2011-09-30 $504
2011-06-30 $510
2011-03-31 $481
2010-12-31 $437
2010-09-30 $441
2010-06-30 $404
2010-03-31 $405
2009-12-31 $397
2009-09-30 $399
2009-06-30 $396
2009-03-31 $356
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.428B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13